Skip to main content
. 2018 Jun 26;10:1781–1789. doi: 10.2147/CMAR.S166971

Figure 4.

Figure 4

Low PPARα (cytoplasm) expression is associated with unfavorable outcomes in subgroups of HCC patients.

Notes: A stratified survival analysis was conducted for PPARα (cytoplasm) expression and unfavorable outcomes in single (A) and multinodular HCC (D), in HCCs with complete (B) and incomplete involucrum (E), in HCCs with TNM stage I–II (C) and stage III–IV (F).

Abbreviations: PPARα, peroxisome proliferator-activated receptor α; HCC, hepatocellular carcinoma.